Board of Directors
Chief Development Officer
Cardinal Health acquired Beckloff Associates in 2004, where Mike continued until transitioning to Silvergate Pharmaceuticals as Chief Development Officer, with a focus on developing and delivering high-quality pediatric drug products. Mike is responsible for all R&D functions, including new product development and approval, and his team of highly skilled drug development professionals has been responsible for guiding the development of all of Silvergate products, resulting in five approved and commercial NDA drug products.
Mike received his Cellular Biology Degree from the University of Kansas.